A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.
Hasford, J
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group. [electronic resource] - Journal of the National Cancer Institute Jun 1998 - 850-8 p. digital
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
0027-8874
10.1093/jnci/90.11.850 doi
Adult
Aged
Antineoplastic Agents--therapeutic use
Blood Cell Count
Europe--epidemiology
Female
Humans
Immunologic Factors--therapeutic use
Interferon-alpha--therapeutic use
Japan--epidemiology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--mortality
Male
Middle Aged
Prognosis
Risk Factors
Severity of Illness Index
Survival Analysis
Survival Rate
United States--epidemiology
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group. [electronic resource] - Journal of the National Cancer Institute Jun 1998 - 850-8 p. digital
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
0027-8874
10.1093/jnci/90.11.850 doi
Adult
Aged
Antineoplastic Agents--therapeutic use
Blood Cell Count
Europe--epidemiology
Female
Humans
Immunologic Factors--therapeutic use
Interferon-alpha--therapeutic use
Japan--epidemiology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--mortality
Male
Middle Aged
Prognosis
Risk Factors
Severity of Illness Index
Survival Analysis
Survival Rate
United States--epidemiology